Morrisville, N.C. – January 21st 2020 - Q2 Solutions, a leading clinical trial laboratory services organization, is honored to be recognized as one of the Top 10 Genomics Solution Providers of 2019 by Pharma Tech Outlook. For their December 2019 edition, Pharma Tech Outlook interviewed Kellie Yarnell, VP of Genomics Laboratories at Q2 Solutions, where she provided insight into Q2 Solutions’ mission and the vision of their genomics laboratory for 2020 and beyond.
Click here to read the Q2 Solutions article generated from Kellie’s interview. Click here to view this edition of Pharma Tech Outlook.
About Q2 Solutions
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. Q2 Solutions’ industry-leading genomic and bioinformatics services provide customers with DNA and RNA sequencing and other testing as well as the ability to mine data for invaluable insights for drug discovery, precision medicine and clinical development. Q2 Solutions works with clients, using a wide array of technology platforms, to ensure maximum efficiency and quality delivery for every study. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.